Invesco Ltd. Cerus Corp Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Cerus Corp stock. As of the latest transaction made, Invesco Ltd. holds 79,723 shares of CERS stock, worth $141,906. This represents 0.0% of its overall portfolio holdings.

Number of Shares

79,723

Previous 76,596 4.08%

Holding current value

$141,906

Previous $144,000 2.78%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.62 - $2.04 $5,065 - $6,379	3,127 Added 4.08%	79,723 $140,000
Q1 2024 May 14, 2024	SELL	$1.66 - $2.42 $2,174 - $3,170	-1,310 Reduced 1.68%	76,596 $144,000
Q4 2023 Feb 12, 2024	SELL	$1.25 - $2.35 $20,060 - $37,712	-16,048 Reduced 17.08%	77,906 $168,000
Q3 2023 Nov 13, 2023	BUY	$1.5 - $3.07 $2,670 - $5,464	1,780 Added 1.93%	93,954 $152,000
Q2 2023 Aug 11, 2023	BUY	$1.79 - $2.9 $28,643 - $46,405	16,002 Added 21.01%	92,174 $226,000
Q1 2023 May 12, 2023	BUY	$2.65 - $3.81 $9,651 - $13,876	3,642 Added 5.02%	76,172 $226,000
Q4 2022 Feb 13, 2023	SELL	$3.38 - $4.22 $24,163 - $30,168	-7,149 Reduced 8.97%	72,530 $264,000
Q3 2022 Nov 14, 2022	SELL	$3.43 - $5.83 $11,922 - $20,265	-3,476 Reduced 4.18%	79,679 $286,000
Q2 2022 Aug 15, 2022	BUY	$4.41 - $5.69 $51,808 - $66,846	11,748 Added 16.45%	83,155 $440,000
Q1 2022 May 16, 2022	SELL	$4.81 - $6.99 $8,975 - $13,043	-1,866 Reduced 2.55%	71,407 $392,000
Q4 2021 Feb 14, 2022	SELL	$5.97 - $7.93 $9,295 - $12,347	-1,557 Reduced 2.08%	73,273 $499,000
Q3 2021 Nov 15, 2021	BUY	$4.79 - $6.68 $68,923 - $96,118	14,389 Added 23.81%	74,830 $455,000
Q2 2021 Aug 17, 2021	BUY	$5.35 - $6.35 $48,754 - $57,867	9,113 Added 17.75%	60,441 $356,000
Q1 2021 May 17, 2021	BUY	$5.68 - $7.87 $93,345 - $129,335	16,434 Added 47.1%	51,328 $309,000
Q4 2020 Feb 16, 2021	BUY	$5.25 - $8.56 $119,217 - $194,380	22,708 Added 186.34%	34,894 $242,000
Q3 2020 Nov 16, 2020	BUY	$5.78 - $7.47 $2,612 - $3,376	452 Added 3.85%	12,186 $76,000
Q2 2020 Aug 14, 2020	BUY	$4.5 - $7.02 $52,803 - $82,372	11,734 New	11,734 $77,000
Q2 2019 Aug 14, 2019	SELL	$4.51 - $6.6 $837,245 - $1.23 Million	-185,642 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.16 - $6.85 $957,912 - $1.27 Million	185,642 New	185,642 $1.16 Million

Others Institutions Holding CERS

# of Institutions

150

Shares Held

145M

Call Options Held

191K

Put Options Held

43.9K

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $315M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account